170 related articles for article (PubMed ID: 22286571)
41. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group.
Tashkin DP; Altose MD; Bleecker ER; Connett JE; Kanner RE; Lee WW; Wise R
Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):301-10. PubMed ID: 1736734
[TBL] [Abstract][Full Text] [Related]
42. Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking.
Miller MR; Sigsgaard T; Omland O; Pedersen OF
Eur Respir J; 2002 Jul; 20(1):86-91. PubMed ID: 12166587
[TBL] [Abstract][Full Text] [Related]
43. Influence of long-term cigarette smoking on immunoglobulin E-mediated allergy, pulmonary function, and high-resolution computed tomography lung densitometry in elderly patients with asthma.
Mitsunobu F; Ashida K; Hosaki Y; Tsugeno H; Okamoto M; Nishida N; Nagata T; Tanizaki Y; Tanimoto M
Clin Exp Allergy; 2004 Jan; 34(1):59-64. PubMed ID: 14720263
[TBL] [Abstract][Full Text] [Related]
44. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.
Kanner RE; Anthonisen NR; Connett JE;
Am J Respir Crit Care Med; 2001 Aug; 164(3):358-64. PubMed ID: 11500333
[TBL] [Abstract][Full Text] [Related]
45. The influence of smoking on asthma in the real-life.
Sprio AE; Ciprandi G; Riccardi E; Giannoccaro F; Carriero V; Bertolini F; Ricciardolo FLM
Respir Med; 2020; 170():106066. PubMed ID: 32843181
[TBL] [Abstract][Full Text] [Related]
46. What role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population.
Medbø A; Melbye H
Scand J Prim Health Care; 2008; 26(2):92-8. PubMed ID: 18570007
[TBL] [Abstract][Full Text] [Related]
47. Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma.
Yoshida M; Kaneko Y; Ishimatsu A; Komori M; Iwanaga T; Inoue H
Pulm Pharmacol Ther; 2017 Feb; 42():7-12. PubMed ID: 27888045
[TBL] [Abstract][Full Text] [Related]
48. Relationships between pulmonary function and changes in chronic respiratory symptoms. Comparison of Tucson and Cracow longitudinal studies.
Krzyzanowski M; Camilli AE; Lebowitz MD
Chest; 1990 Jul; 98(1):62-70. PubMed ID: 2361414
[TBL] [Abstract][Full Text] [Related]
49. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.
Grol MH; Gerritsen J; Vonk JM; Schouten JP; Koëter GH; Rijcken B; Postma DS
Am J Respir Crit Care Med; 1999 Dec; 160(6):1830-7. PubMed ID: 10588593
[TBL] [Abstract][Full Text] [Related]
51. Asthma phenotypes according to the timing of smoking onset in young adults.
Raherison C; Baldi I; Tunon-De-Lara JM; Taytard A; Annesi-Maesano I
Int J Tuberc Lung Dis; 2003 Jan; 7(1):84-92. PubMed ID: 12701840
[TBL] [Abstract][Full Text] [Related]
52. Rate of decline of lung function in subjects with asthma.
Peat JK; Woolcock AJ; Cullen K
Eur J Respir Dis; 1987 Mar; 70(3):171-9. PubMed ID: 3569449
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and severity of asthma in the elderly: results of a large survey in 1,485 asthmatics recruited by lung specialists.
Zureik M; Orehek J
Respiration; 2002; 69(3):223-8. PubMed ID: 12097765
[TBL] [Abstract][Full Text] [Related]
54. Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions.
Gratziou Ch; Florou A; Ischaki E; Eleftheriou K; Sachlas A; Bersimis S; Zakynthinos S
Respir Med; 2014 Apr; 108(4):577-83. PubMed ID: 24560410
[TBL] [Abstract][Full Text] [Related]
55. Voluntary lung function screening to reveal new COPD cases in southern Italy.
Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
[TBL] [Abstract][Full Text] [Related]
56. A population-based clinical study of allergic and non-allergic asthma.
Knudsen TB; Thomsen SF; Nolte H; Backer V
J Asthma; 2009 Feb; 46(1):91-4. PubMed ID: 19191145
[TBL] [Abstract][Full Text] [Related]
57. Bronchial reactivity to cigarette smoke; relation to lung function, respiratory symptoms, serum-immunoglobulin E and blood eosinophil and leukocyte counts.
Jensen EJ; Dahl R; Steffensen F
Respir Med; 2000 Feb; 94(2):119-27. PubMed ID: 10714416
[TBL] [Abstract][Full Text] [Related]
58. Systematic review of the evidence relating FEV1 decline to giving up smoking.
Lee PN; Fry JS
BMC Med; 2010 Dec; 8():84. PubMed ID: 21156048
[TBL] [Abstract][Full Text] [Related]
59. Body mass index, weight gain, and other determinants of lung function decline in adult asthma.
Marcon A; Corsico A; Cazzoletti L; Bugiani M; Accordini S; Almar E; Cerveri I; Gislason D; Gulsvik A; Janson C; Jarvis D; Martínez-Moratalla J; Pin I; de Marco R;
J Allergy Clin Immunol; 2009 May; 123(5):1069-74, 1074.e1-4. PubMed ID: 19321196
[TBL] [Abstract][Full Text] [Related]
60. Occupation and three-year incidence of respiratory symptoms and lung function decline: the ARIC Study.
Mirabelli MC; London SJ; Charles LE; Pompeii LA; Wagenknecht LE
Respir Res; 2012 Mar; 13(1):24. PubMed ID: 22433119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
